Renowned Facial Plastic Surgeon/Otolaryngologist, Dr. Maurice Khosh, nominated for inclusion in New York Magazine’s 2021 Best Doctors List
Share Article
The publication works with Castle Connolly’s physician-led medical team to conduct a peer-review survey, determining a select group of candidates who meet a high-level of qualifications.
It’s an honor and a privilege to be selected as one of New York Magazine’s Best Doctors, says Dr. Khosh NEW YORK (PRWEB) December 15, 2020 Dr. Maurice Khosh has been selected for New York Magazine’s upcoming annual list of physicians who are recommended by their peers and efficiently screened by Castle Connolly. The New York Magazine Best Doctors selection process is challenging, with professional qualifications, education, board certification and the disciplinary record being taken into consideration. Dr. Khosh ranks highly among a select group of plastic surgeons who
Share this article
Share this article
ResearchAndMarkets.com s offering.
The report gives insights into the transformational microbiome landscape. It is a rigorous assessment of the industry trends supported by detailed segmentation across publications, grants, clinical trials, and startup funding activity.
The dataset behind the report is based on real world evidence that will drive actionable business insights. Follow trends over the years captured across publications, grants, clinical trials, and startup funding activity to power data driven marketing campaigns to fund raising to investor pitches, and business/corporate development activities. Tap into premium data sources that leverage NLP and relational search paradigm to uncover relevant data points, all in one package.
Medically Reviewed
Both migraine and cluster headache tend to affect primarily one side of the head, but cluster headache typically causes a runny nose and tearing eye in addition to pain.
iStock; Everyday Health
Whether you’re having a migraine attack or a cluster headache, the pain it causes can be debilitating.
But because the treatments for the two diseases are very different, it’s crucial to figure out which you have or whether you have something else entirely to have the best chance at easing your pain.
Without the correct diagnosis, it’s difficult to find relief for your headache, says Merle L. Diamond, MD, associate director of the Diamond Headache Clinic in Chicago.
email article
SAN ANTONIO An online tool, which incorporates clinicopathological data and the results of the 21-gene recurrent score, was able to estimate risk of distant recurrence (DR) and adjuvant chemotherapy benefit in certain patients with breast cancer, a researcher reported.
The RSClin tool integrates the recurrence score (RS) with tumor grade, tumor size, and age using a patient-specific meta-analysis that included 10,004 women with hormone receptor-positive, HER2-negative, and node-negative breast cancer who received endocrine therapy alone in the B-14 trial, or with chemotherapy in the TAILORx trial, explained Joseph Sparano, MD, of Montefiore Medical Center and the Albert Einstein College of Medicine in New York City, at the San Antonio Breast Cancer Symposium virtual meeting. The study was simultaneously published in the
Health Disparities Symposium Presenters | NYU Langone Health We use cookies and similar tools to give you the best website experience. By using our site, you accept our digital privacy statement NYU Grossman School of Medicine Explore NYU Langone Health
Health Disparities Symposium Presenters
NYU Langone’s Section for Health Equity was honored to host Mary T. Bassett, MD, MPH, as the keynote speaker for the 2020 Health Disparities Symposium, which was centered around the theme “Turning Research into Action.”
Keynote Address
With more than 30 years of experience in public health, Dr. Mary T. Bassett has dedicated her career to advancing health equity. Dr. Bassett is currently the director of the François-Xavier Bagnoud (FXB) Center for Health and Human Rights at Harvard University and the FXB Professor of the Practice of Health and Human Rights at the Harvard T.H. Chan School of Public Hea